Sophie Bushwick, senior editor for Popular Science, discusses the Trump administration's recent announcement to scale back the size of two national monuments in Utah, which are home to over 400 research sites employing 2,000 scientists. The administration will scale back the size of Grand Staircase-Escalante and Bear's End. Scientists are suing to reverse the decision because of the disruption it will cause in paleontology and other scientific research endeavors. We discuss Patagonia and R.E.I.'s opposition to the decision and whether a compromise can be made between the government and researchers.

Share:
More In Science
One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More